We speculate that Prkar1b, Prkacb and GluR3, commonly downregulated in both restraint stress and in a model of TNBC, may be novel drug targets to enhance cognitive impairment caused by the stress and anxiety of a cancer diagnosis (Wong et al. 2014; Wu et al. 2007). The gene discussed is PRKAR1B; the disease is Cognitive impairment.